Your session is about to expire
← Back to Search
Exendin-9,39 for High Blood Sugar in Healthy Subjects
Study Summary
This trial is investigating how different versions of the GLP1R gene affect insulin secretion in people with and without diabetes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 25 and 65 years old.My genetic test shows I have either the AA or GG genotype at rs3765467.I am not diabetic.I am either younger than 25 or older than 65.
- Group 1: Saline
- Group 2: Exendin-9,39
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the present regulatory status of Exendin-9,39?
"Exendin-9,39's Phase 3 status indicates that, while more safety data is needed, there is enough efficacy data and supporting safety data to warrant a score of 3."
Does this particular research project allow senior citizens to enroll?
"In order for an individual to participate in this clinical trial, they must be aged 25-65. There are currently 57 trials underway for patients younger than 18 and 446 for those older than 65."
Could I take part in this clinical trial if I take this medication?
"This study requires 40 test subjects that are between 25 and 65 years old and considered to be healthy. Out of the 40 subjects, 20 must have the AA genotype at rs3765467, while the other 20 can have any genotype."
Are there any patients that this research project is looking for right now?
"According to the latest update on clinicaltrials.gov, this study is not presently looking for patients. The trial was initially posted on 10/1/2022 and was last edited on 7/28/2022. However, there are 951 other trials that are presently searching for participants."
Share this study with friends
Copy Link
Messenger